Neovasc Announces Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Neovasc (NVCN) Reports Q3 Loss of $0.70, Revenues Miss
November 14, 2018 4:01 PM ESTNeovasc (NASDAQ: NVCN) reported Q3 EPS of ($0.70), versus ($0.05) reported last year. Revenue for the quarter came in at $480 thousand versus the consensus estimate of $1.16 million.
"In the first nine months of 2018, we successfully managed several critical corporate events and achieved many significant therapy development milestones for both of our product platforms. As a result, the Company is now on a stronger foundation from which to continue advancing our product development, clinical and commercial programs for the Reducer and Tiara," said Fred... More
